Manchester man with Covid-19 first in UK to be given experimental arthritis drug under clinical treatment trial
manchestereveningnews.co.ukhere"We are conducting this study to see whether otilimab - which is under investigation as a potential treatment for rheumatoid arthritis - could also potentially ease the effect of coronavirus on the lungs, dampening the impact of the virus on the immune system."Funded by GlaxoSmithKline (GSK), a UK-based pharmaceutical company, 'Oscar' is one of a number of Covid-19 studies that have been given urgent public health research status by the Department of Health and Social Care.Trials in the US are already underway.There are plans to recruit 800 patients globally for the study, and GSK has said it's aiming to utilise five hospitals in the UK.Those taking part will be allocated into two groups at random, with half receiving a one-hour, single.
Read more on manchestereveningnews.co.uk
